课题基金 / 基金详情

Regulatory and functional pathways mediating the control of central osmotic defences by hypothalamic transcription factor CREB3L1

Regulatory and functional pathways mediating the control of central osmotic defences by hypothalamic transcription factor CREB3L1
下丘脑转录因子 CREB3L1 介导中枢渗透防御控制的调节和功能途径
批准号:
MR/N022807/1
负责人:
David Murphy
金额:
$55.09万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --

项目摘要

项目成果

David Murphy的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The bodily fluids of the mammalian organism are in a constant state of flux. Even in the absence of challenges such as dehydration, haemorrhage or starvation, salt and water are constantly being lost as a consequence of normal, obligatory renal excretory functions, and by the processes of respiration and perspiration. The body has two mechanisms that function to control the consumption and the excretion of water and salt, in order to maintain the optimal bodily content required for good health. The first mechanism involves the production, by a part of the brain called the hypothalamus, of a hormone called "arginine vasopressin" (AVP) that tells the kidney to conserve water. The second mechanism is behavioural, and involves the instincts of thirst and salt appetite that emotionally drive the organism to correct its fluid balance. These mechanisms can go wrong resulting in ill-health. For example, disorders of fluid balance are evident in a substantial proportion of elderly patients admitted to hospital, and dehydration is a frequent cause of morbidity and mortality in old people. AVP is a peptide hormone that is encoded by the corresponding AVP gene. When an animal becomes dehydrated, AVP is released from the hypothalamus and there is thus a need to make more. Twenty five years ago, we showed that the expression of the AVP gene is hence activated, and more messenger RNA (mRNA) is made from the gene, a process known as "transcription". It is the AVP mRNA that take the information coded by the gene to the cytoplasm of the cell. Here, the information in the mRNA is "translated" into protein. However, the exact molecular mechanisms involved have remained elusive, until now. Using methods that allow us to simultaneously describe the expression of all genes, we identified another gene, called CREB3L1, as being increased in expression in the hypothalamus following dehydration. CREB3L1 is a specialised protein (a "transcription factor") that controls the expression of target genes. We showed that CREB3L1 is expressed in AVP neurones, binds to the promoter region of the AVP gene, and hence drives its expression. Our aims are now to decipher the detailed molecular mechanisms by which CREB3L1 affects gene expression in the hypothalamus, and hence regulates the crucial hormonal processes that govern salt and water homeostasis. We will:*work out which signals tell the hypothalamus to increase the expression of CREB3L1 following dehydration.*find out what other proteins are bound to CREB3L1, which will tell us about upstream factors that regulate CREB3L1, and downstream effectors through which CREB3L1 might exerts its action. *find out what other genes in the AVP cell are regulated by CREB3L1. *determine how CREB3L1 globally affects the elaboration of neuropeptides in the hypothalamus. *embark upon studies that will tell us about the physiological roles of CREB3L1, the proteins that it interacts with and the genes that it regulates. Importantly, these experiments will take place in the physiological integrity of the whole organism. These unique studies will tell us about the mechanisms by which transcription factor protein affects gene expression in the brain, and hence mediates physiological stability.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.molmet.2022.101542
发表时间: 2022-09
期刊: MOLECULAR METABOLISM
影响因子: 8.1
作者: [Greenwood, Mingkwan, Gillard, Benjamin T., Farrukh, Rizwan, Paterson, Alex, Althammer, Ferdinand, Grinevich, Valery, Murphy, David, Greenwood, Michael P.]
通讯作者: Greenwood, Michael P.
DOI: 10.3389/fvets.2023.1236425
发表时间: 2023
期刊: Frontiers in veterinary science
影响因子: 3.2
作者: []
通讯作者:
DOI: 10.1016/j.neurobiolaging.2018.01.008
发表时间: 2018-05
期刊: Neurobiology of aging
影响因子: 4.2
作者: [Greenwood MP, Greenwood M, Romanova EV, Mecawi AS, Paterson A, Sarenac O, Japundžić-Žigon N, Antunes-Rodrigues J, Paton JFR, Sweedler JV, Murphy D]
通讯作者: Murphy D
DOI: 10.1016/j.molmet.2023.101692
发表时间: 2023-04
期刊: MOLECULAR METABOLISM
影响因子: 8.1
作者: [Greenwood, Michael P., Greenwood, Mingkwan, Barez-Lopez, Soledad, Hawkins, Joe W., Short, Katherine, Tatovic, Danijela, Murphy, David]
通讯作者: Murphy, David
6
    Dynamic integration of ingestive behaviours and homeostasis by hypothalamo-neurohypophysial system glucagon like peptide 1 receptors
    • 批准号:
      MR/W028999/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $59.52万
    • 财政年份:
      2022
    • 负责人:
      David Murphy
    • 依托单位:
    CAREER: Aerial and Aquatic Flapping Flight at Low Reynolds Numbers
    • 批准号:
      1846925
    • 项目类别:
      Continuing Grant
    • 资助金额:
      $52.0万
    • 财政年份:
      2019
    • 负责人:
      David Murphy
    • 依托单位:
    Collaborative Research: Individual Based Approaches to Understanding Krill Distributions and Aggregations
    • 批准号:
      1840941
    • 项目类别:
      Standard Grant
    • 资助金额:
      $19.79万
    • 财政年份:
      2019
    • 负责人:
      David Murphy
    • 依托单位:
    The neurohumoral control of body fluid and cardiovascular homeostasis in males and females - vive la difference!
    • 批准号:
      BB/S019928/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $1.28万
    • 财政年份:
      2019
    • 负责人:
      David Murphy
    • 依托单位:
    国内基金
    海外基金
    Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
    • 批准号:
      82371801
    • 项目类别:
      面上项目
    • 资助金额:
      47.00万元
    • 批准年份:
      2023
    • 负责人:
      周海波
    • 依托单位:
    基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
    • 批准号:
      82371373
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      沃雁
    • 依托单位:
    利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
    • 批准号:
      82371145
    • 项目类别:
      面上项目
    • 资助金额:
      46.00万元
    • 批准年份:
      2023
    • 负责人:
      陶永
    • 依托单位:
    SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
    • 批准号:
      82371873
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2023
    • 负责人:
      乔洁
    • 依托单位: